Expertise in
25
conditions

Dr. Mordechai Rabinovitz

Hepatology
University Of Pittsburgh Physicians
600 Oxford Dr, Suite 210, 
Monroeville, PA 
Clinical Trials:Currently Recruiting for 1 Trial
Offers Telehealth
47 Years of Experience
Expertise in
25
conditions
University Of Pittsburgh Physicians
600 Oxford Dr, Suite 210, 
Monroeville, PA 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Mordechai Rabinovitz is a Hepatologist in Monroeville, Pennsylvania. Dr. Rabinovitz has been practicing medicine for over 47 years is highly rated in 25 conditions, according to our data. His top areas of expertise are Hepatitis C, Hepatitis, Cirrhosis, Endoscopy, and Liver Transplant.

His clinical research consists of co-authoring 19 peer reviewed articles and participating in 7 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Hepatology
Licenses
Specialist in PA
Hospital Affiliations
Magee Womens Hospital Of Upmc Health System
Upmc Presbyterian Shadyside
Upmc St Margaret
Penn Highlands Dubois
Upmc Passavant
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
AmeriHealth
  • EPO
  • HMO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Change Healthcare
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Cigna
  • EPO
  • HMO
  • PPO
Gateway Health Plan
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE SNP
  • OTHER MEDICARE PART D
Geisinger
  • HMO
  • POS
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Health Partners Plans
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independence
  • EPO
  • HMO
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medical Mutual
  • HMO
  • PPO
PA Health and Wellness
  • HMO
  • MANAGED MEDICAID PLAN
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
UPMC
  • EPO
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 15 Less Insurance Carriers -

Locations

UNIVERSITY OF PITTSBURGH PHYSICIANS
600 Oxford Dr, Suite 210, Monroeville, PA 15146
Other Locations
UNIVERSITY OF PITTSBURGH PHYSICIANS
300 Halket St, Pittsburgh, PA 15213
UNIVERSITY OF PITTSBURGH PHYSICIANS
200 Lothrop St, Pittsburgh, PA 15213

Additional Areas of Focus

Dr. Rabinovitz has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Non-Alcoholic Fatty Liver Disease
Nonalcoholic Steatohepatitis (NASH)

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

A Randomized Double-Blind Placebo-Controlled Study to Evaluate the Efficacy and Safety of Volixibat in the Treatment of Cholestatic Pruritus in Patients With Primary Sclerosing Cholangitis
A Randomized Double-Blind Placebo-Controlled Study to Evaluate the Efficacy and Safety of Volixibat in the Treatment of Cholestatic Pruritus in Patients With Primary Sclerosing Cholangitis
Enrollment Status: Recruiting
Publish Date: June 06, 2025
Intervention Type: Drug
Study Drug: Volixibat
Study Phase: Phase 2
Phase IIb Multi-Center, Randomised, Partial-Blind Parallel Cohort Study to Assess the Efficacy and Safety of Treatment With GSK3228836 in Participants With Chronic Hepatitis B Virus (B-Clear)
Phase IIb Multi-Center, Randomised, Partial-Blind Parallel Cohort Study to Assess the Efficacy and Safety of Treatment With GSK3228836 in Participants With Chronic Hepatitis B Virus (B-Clear)
Enrollment Status: Completed
Publish Date: May 16, 2023
Intervention Type: Drug
Study Drugs: GSK3228836, Nucleos(t)ide therapy
Study Phase: Phase 2
A Phase 4, Double-Blind, Randomized, Placebo-Controlled Study Evaluating the Pharmacokinetics and Safety of Obeticholic Acid in Patients With Primary Biliary Cholangitis and Moderate to Severe Hepatic Impairment
A Phase 4, Double-Blind, Randomized, Placebo-Controlled Study Evaluating the Pharmacokinetics and Safety of Obeticholic Acid in Patients With Primary Biliary Cholangitis and Moderate to Severe Hepatic Impairment
Enrollment Status: Terminated
Publish Date: September 06, 2022
Intervention Type: Drug
Study Drug: Obeticholic Acid
Study Phase: Phase 4
A 52-week, Placebo-controlled, Randomized, Phase 3 Study to Evaluate the Safety and Efficacy of Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and an Inadequate Response to or an Intolerance to Ursodeoxycholic Acid (UDCA)
A 52-week, Placebo-controlled, Randomized, Phase 3 Study to Evaluate the Safety and Efficacy of Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and an Inadequate Response to or an Intolerance to Ursodeoxycholic Acid (UDCA)
Enrollment Status: Completed
Publish Date: August 02, 2022
Intervention Type: Drug
Study Phase: Phase 3
Per-Oral Cholangioscopy in Liver Transplantation Patients
Per-Oral Cholangioscopy in Liver Transplantation Patients
Enrollment Status: Completed
Publish Date: July 28, 2022
Intervention Type: Device
A Phase 2 Dose Ranging, Randomized, Double Blind, Placebo-Controlled Study Evaluating the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects With Primary Biliary Cholangitis (PBC) With or Without an Inadequate Response to Ursodeoxycholic Acid (UDCA)
A Phase 2 Dose Ranging, Randomized, Double Blind, Placebo-Controlled Study Evaluating the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects With Primary Biliary Cholangitis (PBC) With or Without an Inadequate Response to Ursodeoxycholic Acid (UDCA)
Enrollment Status: Completed
Publish Date: May 18, 2021
Intervention Type: Drug
Study Phase: Phase 2
A Randomized, Double-Blind, Placebo-Controlled, Proof-of-Concept Study Evaluating the Efficacy and Safety of Baricitinib (LY3009104) in Patients With Primary Biliary Cholangitis Who Have an Inadequate Response or Are Intolerant to UDCA
A Randomized, Double-Blind, Placebo-Controlled, Proof-of-Concept Study Evaluating the Efficacy and Safety of Baricitinib (LY3009104) in Patients With Primary Biliary Cholangitis Who Have an Inadequate Response or Are Intolerant to UDCA
Enrollment Status: Terminated
Publish Date: October 14, 2020
Intervention Type: Drug
Study Phase: Phase 2
View 6 Less Clinical Trials

19 Total Publications

Natural history of spontaneous pancreatic portal vein fistulae: A systematic review of the literature.
Natural history of spontaneous pancreatic portal vein fistulae: A systematic review of the literature.
Journal: Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]
Published: April 23, 2024
Similar Doctors
Expertise in
17
conditions
Dr. Jaideep Behari
Hepatology
Expertise in
17
conditions
Dr. Jaideep Behari
Hepatology

University Of Pittsburgh Physicians

300 Halket St, 
Pittsburgh, PA 
 (9.1 mi)
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Jaideep Behari is a Hepatologist in Pittsburgh, Pennsylvania. Dr. Behari is highly rated in 17 conditions, according to our data. His top areas of expertise are Non-Alcoholic Fatty Liver Disease, Nonalcoholic Steatohepatitis (NASH), Cirrhosis, Liver Transplant, and Endoscopy.

Expertise in
11
conditions
Dr. Scott W. Biggins
Hepatology
Expertise in
11
conditions
Dr. Scott W. Biggins
Hepatology

University Of Pittsburgh Physicians

200 Lothrop St, 
Pittsburgh, PA 
 (9.1 mi)
Languages Spoken:
English
See accepted insurances

Scott Biggins is a Hepatologist in Pittsburgh, Pennsylvania. Dr. Biggins is highly rated in 11 conditions, according to our data. His top areas of expertise are Liver Failure, Ascites, Cirrhosis, Spontaneous Bacterial Peritonitis, and Liver Transplant.

Expertise in
24
conditions
Dr. Kapil B. Chopra
Hepatology
Expertise in
24
conditions
Dr. Kapil B. Chopra
Hepatology

University Of Pittsburgh Physicians

300 Halket St, 
Pittsburgh, PA 
 (9.1 mi)
Languages Spoken:
English
See accepted insurances

Kapil Chopra is a Hepatologist in Pittsburgh, Pennsylvania. Dr. Chopra is highly rated in 24 conditions, according to our data. His top areas of expertise are Cirrhosis, Visceromegaly, Non-Alcoholic Fatty Liver Disease, Endoscopy, and Liver Transplant.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Rabinovitz's expertise for a condition
ConditionClose
    View All 13 Distinguished Conditions
    View All 12 Advanced Conditions
    View All 14 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile